eastman kodak said has acquired pct equity interest enzon inc pharmaceutical company specializing protein therapy kodak said secured worldwide marketing rights for three enzon peg enzymes used treatment oxygen toxicity disorders hyperuricemia and gout company said acquired two mln enzon shares for mln dlrs with loans enzon two mln dlrs and interest 000 dlrs credited against purchase price kodak said drugs covered marketing rights initial stages food and drug administration approval process said investment should necessary capital complete fda review process and marketing outlet for drugs drugs peg superoxide disdmutase and peg catalase for against oxygen toxicity disorders often fatal tissue damage associated with severe burns organ transplants heart attacks and trauma and peg uricase for treatment gout and conditions caused buildup high levels uric acid body reuter 